免疫性血小板减少-话题@MedSci

#免疫性血小板减少#

41篇内容 | 1877人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1754078, encodeId=26d61e540782c, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验, objectType=article, longId=178212, objectId=d4f41e82121f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4f41e82121f, replyNumber=0, likeNumber=64, createdTime=2020-04-08, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4f41e82121f, moduleTitle=Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4f41e82121f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754075, encodeId=f9601e54075e0, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=FDA批准Amgen的Nplate治疗儿科免疫性血小板减少症, objectType=article, longId=155933, objectId=5a611559332d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a611559332d, replyNumber=0, likeNumber=92, createdTime=2019-03-21, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a611559332d, moduleTitle=FDA批准Amgen的Nplate治疗儿科免疫性血小板减少症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a611559332d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754073, encodeId=95961e540738d, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=PNAS：苏州大学全新发现：免疫性血小板减少症的发生新机制, objectType=article, longId=153118, objectId=835015311801, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=835015311801, replyNumber=0, likeNumber=115, createdTime=2018-11-23, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=835015311801, moduleTitle=PNAS：苏州大学全新发现：免疫性血小板减少症的发生新机制, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=835015311801)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754074, encodeId=9a0b1e5407406, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=王天有：儿童免疫性血小板减少症的诊疗与管理, objectType=article, longId=153491, objectId=d2b1153491b7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b1153491b7, replyNumber=0, likeNumber=66, createdTime=2019-08-11, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b1153491b7, moduleTitle=王天有：儿童免疫性血小板减少症的诊疗与管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2b1153491b7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754072, encodeId=e48a1e540729f, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, objectType=article, longId=151535, objectId=817b1515353f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=817b1515353f, replyNumber=0, likeNumber=65, createdTime=2019-08-30, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=817b1515353f, moduleTitle=Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=817b1515353f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754071, encodeId=c1101e5407179, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析, objectType=article, longId=142832, objectId=10f014283224, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=10f014283224, replyNumber=0, likeNumber=140, createdTime=2019-04-04, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=10f014283224, moduleTitle=J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=10f014283224)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754069, encodeId=49291e540698d, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood：免疫性血小板减少研究新进展, objectType=article, longId=132819, objectId=9788132819f7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9788132819f7, replyNumber=0, likeNumber=78, createdTime=2018-11-12, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9788132819f7, moduleTitle=Blood：免疫性血小板减少研究新进展, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9788132819f7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754070, encodeId=ee731e54070ef, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, objectType=article, longId=135793, objectId=34e3135e935e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34e3135e935e, replyNumber=0, likeNumber=57, createdTime=2018-10-18, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34e3135e935e, moduleTitle=FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34e3135e935e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754067, encodeId=78721e5406785, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, objectType=article, longId=125208, objectId=c66f1252082a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c66f1252082a, replyNumber=0, likeNumber=66, createdTime=2018-10-11, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c66f1252082a, moduleTitle=Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c66f1252082a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754065, encodeId=c5c21e5406534, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood：重组人血小板生成素治疗妊娠期免疫性血小板减少症安全且有效, objectType=article, longId=103106, objectId=13d010310690, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=13d010310690, replyNumber=0, likeNumber=65, createdTime=2018-03-18, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=13d010310690, moduleTitle=Blood：重组人血小板生成素治疗妊娠期免疫性血小板减少症安全且有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=13d010310690)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754068, encodeId=8cc71e540682b, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, objectType=article, longId=125569, objectId=e81912556915, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e81912556915, replyNumber=0, likeNumber=66, createdTime=2018-02-28, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e81912556915, moduleTitle=Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e81912556915)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754066, encodeId=6bd11e5406613, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。, objectType=article, longId=112811, objectId=d4ff112811cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d4ff112811cb, replyNumber=0, likeNumber=66, createdTime=2017-12-09, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d4ff112811cb, moduleTitle=Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d4ff112811cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754063, encodeId=2ff21e540639a, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet子刊：高剂量地塞米松对于免疫性血小板减少症效果并不理想, objectType=article, longId=77810, objectId=f4d1e781097, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f4d1e781097, replyNumber=0, likeNumber=72, createdTime=2017-04-02, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f4d1e781097, moduleTitle=Lancet子刊：高剂量地塞米松对于免疫性血小板减少症效果并不理想, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f4d1e781097)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754062, encodeId=405e1e54062ca, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=2016成人原发免疫性血小板减少症诊断与治疗中国专家共识发布, objectType=article, longId=76705, objectId=6e92e670506, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e92e670506, replyNumber=0, likeNumber=66, createdTime=2017-01-13, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e92e670506, moduleTitle=2016成人原发免疫性血小板减少症诊断与治疗中国专家共识发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6e92e670506)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754061, encodeId=62231e540612c, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=2016中医儿科临床诊疗指南——小儿免疫性血小板减少症(制订) 发布, objectType=article, longId=75590, objectId=98f5e5590d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=98f5e5590d0, replyNumber=0, likeNumber=65, createdTime=2017-07-19, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=98f5e5590d0, moduleTitle=2016中医儿科临床诊疗指南——小儿免疫性血小板减少症(制订) 发布, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=98f5e5590d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754064, encodeId=207d1e540648b, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读, objectType=article, longId=81500, objectId=fe1b81500a3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1b81500a3, replyNumber=0, likeNumber=61, createdTime=2017-01-27, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1b81500a3, moduleTitle=【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe1b81500a3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754060, encodeId=06351e54060d2, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效, objectType=article, longId=67290, objectId=46af6e29096, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46af6e29096, replyNumber=0, likeNumber=68, createdTime=2016-10-22, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46af6e29096, moduleTitle=Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46af6e29096)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754059, encodeId=27c81e54059d6, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的, objectType=article, longId=57745, objectId=932f5e74566, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=932f5e74566, replyNumber=0, likeNumber=70, createdTime=2016-04-22, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=932f5e74566, moduleTitle=Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=932f5e74566)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754058, encodeId=17711e54058df, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=Lancet：免疫性血小板减少症使用利妥昔单抗可改善治疗应答, objectType=article, longId=47311, objectId=46694e31173, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=46694e31173, replyNumber=0, likeNumber=69, createdTime=2015-08-07, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=46694e31173, moduleTitle=Lancet：免疫性血小板减少症使用利妥昔单抗可改善治疗应答, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=46694e31173)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1754057, encodeId=08381e54057a2, content=<a href='/topic/show?id=5db12902447' target=_blank style='color:#2F92EE;'>#免疫性血小板减少#</a>, objectTitle=侯明：原发免疫性血小板减少症治疗新策略, objectType=article, longId=6941, objectId=69726941bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=69726941bc, replyNumber=0, likeNumber=76, createdTime=2013-04-01, rootId=0, userName=lily1628, userId=ed4d36658977, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=69726941bc, moduleTitle=侯明：原发免疫性血小板减少症治疗新策略, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=69726941bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

免疫性血小板减少

2020-05-29

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Chi-Med在中国启动HMPL-523治疗免疫性血小板减少症（ITP）的I期临床试验

2020-04-08

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

FDA批准Amgen的Nplate治疗儿科免疫性血小板减少症

2019-03-21

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

PNAS：苏州大学全新发现：免疫性血小板减少症的发生新机制

2018-11-23

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

王天有：儿童免疫性血小板减少症的诊疗与管理

2019-08-11

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Principia 制药宣布PRN1008获得FDA孤儿药认定用于治疗免疫性血小板减少性紫癜

2019-08-30

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

J Thromb Haemost：免疫性血小板减少症成人出血危险因素分析

2019-04-04

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood：免疫性血小板减少研究新进展

2018-11-12

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

FDA批准SYK抑制剂用于治疗慢性免疫性血小板减少性紫癜

2018-10-18

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood：阿伐他丁可增强糖皮质激素耐受性的免疫性血小板减少性紫癜患者的骨髓内皮细胞的功能。

2018-10-11

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood：重组人血小板生成素治疗妊娠期免疫性血小板减少症安全且有效

2018-03-18

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Blood：脾切除仅能缓解特发性免疫性血小板减少性紫癜（ITP）的症状，并不能根治。

2018-02-28

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet haemat：全反式维甲酸联合达那唑治疗原发性免疫性血小板减少症的效果和安全性。

2017-12-09

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet子刊：高剂量地塞米松对于免疫性血小板减少症效果并不理想

2017-04-02

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

2016成人原发免疫性血小板减少症诊断与治疗中国专家共识发布

2017-01-13

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

2016中医儿科临床诊疗指南——小儿免疫性血小板减少症(制订) 发布

2017-07-19

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

【视频】沈志祥教授：原发免疫性血小板减少症（ITP)诊疗中国专家共识解读

2017-01-27

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet：romiplostim对儿童免疫性血小板减少症（ITP）显著疗效

2016-10-22

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lacnet：艾曲波帕对慢性免疫性血小板减少症儿童患者是有效的

2016-04-22

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

Lancet：免疫性血小板减少症使用利妥昔单抗可改善治疗应答

2015-08-07

lily1628 (审核中...)

前往app查看评论内容

#免疫性血小板减少#

侯明：原发免疫性血小板减少症治疗新策略

2013-04-01

科室
- - 订阅+
  - 更多科室
工具
服务